Anti-Cancer Drugs Journal Issues Research Articles in June 2022 Edition
April 18, 2022
April 18, 2022
LONDON, England, April 18 -- Anti-Cancer Drugs, a journal that says it reports clinical and experimental results related to anti-cancer drugs and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation, published research articles on the following topics in its June 2022 edition:
Pre-Clinical Reports:
* The marine factor 3,5-dihydroxy-4-methoxybenzyl alcohol suppresses growth, migrat . . .
Pre-Clinical Reports:
* The marine factor 3,5-dihydroxy-4-methoxybenzyl alcohol suppresses growth, migrat . . .